MK-677 sits on every “SARMs” shelf, gets stacked into SARM cycles, and shows up in SARM reviews — so it’s reasonable to assume it’s one. It isn’t. MK-677 is a growth hormone secretagogue, a completely different class of compound that works through a different receptor and produces a different set of effects.
The mix-up is understandable, but it matters: the two classes diverge on mechanism, side effects, hormone suppression, and how you’d even think about using them in research. Below, we explain what a SARM actually is, what MK-677 actually is, why they keep getting lumped together, and the differences that the “SARM” label hides.
Key Takeaways
No, MK-677 is not a SARM. It’s a growth hormone secretagogue (a ghrelin-receptor agonist), also called ibutamoren.
SARMs act on the androgen receptor; MK-677 acts on the growth hormone secretagogue receptor (GHSR-1a). Different target, different effects.
MK-677 raises growth hormone and IGF-1. SARMs mimic testosterone in muscle and bone. These are not the same pathway.
Key practical difference: SARMs suppress your natural testosterone; MK-677 does not act on that axis at all.
What they share: both are unapproved, both are sold as “research chemicals,” and both are banned in sport — which is largely why they get shelved together.
Bottom line: the “SARM” label on MK-677 is marketing shorthand, not pharmacology. Knowing the difference changes what risks you’d actually expect.
The short answer: is MK-677 a SARM?
No. A SARM is a selective androgen receptor modulator — the name literally describes its mechanism: it modulates the androgen receptor, the same receptor testosterone uses. MK-677 doesn’t touch the androgen receptor. It works on an entirely separate system that controls growth hormone.
So while MK-677 is sold alongside SARMs and used for overlapping goals (muscle, recovery), calling it a SARM is a category error — like calling a diesel engine “a type of electric motor” because both move a car.
What is a SARM?
SARMs (selective androgen receptor modulators) are nonsteroidal compounds designed to stimulate the androgen receptor in muscle and bone — delivering the muscle-building effects of anabolic steroids while aiming for weaker effects in other tissues like the prostate (overview of SARMs as function-promoting therapies).
MK-677 — also called ibutamoren or MK-0677 (PubChem CID 178024) — is an oral growth hormone secretagogue. It mimics ghrelin, the body’s “hunger hormone,” binding the growth hormone secretagogue receptor (GHSR-1a) to make your pituitary release more of your own growth hormone (GH). That, in turn, raises insulin-like growth factor 1 (IGF-1).
In the largest human study — a two-year trial in healthy older adults — MK-677 raised GH and IGF-1 to young-adult levels and increased fat-free mass. Note what that mechanism is about: growth hormone, not androgens.
Raised blood sugar, water retention, appetite, cardiovascular signal
Approved medicine?
No
No
Banned in sport?
Yes
Yes (separate WADA category)
Same shelf, same goals — but mechanistically they have almost nothing in common.
Side effects: MK-677 vs SARMs
Because they act on different receptors, the two classes carry different side-effect profiles — which is the most practical reason the distinction matters. Expecting “SARM side effects” from MK-677 (or vice versa) will point you at the wrong risks. Here’s the split, with deeper guides for each.
MK-677 side effects
MK-677’s risks follow from raising growth hormone and IGF-1, not from androgens. The main ones documented in trials:
Raised blood sugar and reduced insulin sensitivity — its most consistent effect (Nass et al., 2008).
Water retention (edema) and increased appetite — direct consequences of the GH and ghrelin pathways.
For the detail on each SARM and how their risks differ, see our guide: SARMs side effects
Why MK-677 gets mislabeled as a SARM
If they’re so different, why the constant confusion? A few reasons:
They’re sold together. Research-chemical vendors list MK-677 in the same “SARMs” category as ostarine and RAD140, so the label sticks by association.
They’re used for similar goals. Both get marketed for muscle, recovery, and body composition, so users group them by purpose rather than mechanism.
They’re stacked together. MK-677 is frequently combined with SARMs in “cycles,” reinforcing the impression that it’s one of them.
Both are non-steroidal “designer” compounds. Neither is an anabolic steroid, so people reach for the next-nearest label — “SARM” — even though it doesn’t fit.
“SARM” has drifted into a catch-all retail term for non-steroidal performance compounds. Pharmacologically, MK-677 is a growth hormone secretagogue — a separate class with a separate receptor.
Does the distinction actually matter?
Yes — and not as pedantry. The label changes what you’d expect:
Testosterone suppression. Because SARMs hit the androgen receptor, they suppress natural testosterone and prompt discussion of post-cycle recovery. MK-677 doesn’t act on that axis, so that specific concern doesn’t apply to it.
Different side-effect profile. Expecting “SARM side effects” from MK-677 is misleading. Its real risks are metabolic and cardiovascular — raised blood sugar, fluid retention, and a cardiovascular signal that ended one trial early — not androgenic ones.
Drug testing. Both are banned, but they’re detected as different things: athletes are tested for MK-677 as a growth hormone secretagogue under WADA, not as an androgen.
Getting the class right is how you anticipate the right risks.
What MK-677 and SARMs do share
To be fair, the grouping isn’t random. They genuinely overlap on the things a buyer notices:
Both are sold as “research chemicals” and “not for human consumption.”
Both are banned in sport by WADA (just under different categories).
Both are frequently counterfeited, so purity verification matters for either.
These shared regulatory traits — not shared pharmacology — are what put them on the same shelf.
Frequently asked questions
Is MK-677 a SARM or a steroid? Neither. It’s a growth hormone secretagogue (a ghrelin-receptor agonist). It doesn’t act on the androgen receptor like a SARM, and it isn’t an anabolic steroid.
Does MK-677 suppress testosterone like SARMs do? No. SARMs suppress natural testosterone because they act on the androgen receptor. MK-677 works on the growth hormone pathway and doesn’t directly suppress testosterone.
Why is MK-677 sold with SARMs then? Marketing and use-case, not pharmacology. Vendors group non-steroidal performance compounds together, and MK-677 is often stacked with SARMs — so it inherits the label.
Is MK-677 safer than a SARM because it’s not one? Not necessarily — just different. It avoids androgenic suppression but carries its own risks: blood-sugar disruption, water retention, and a cardiovascular signal in trials.
MK-677 is not a SARM. It’s a growth hormone secretagogue that raises your own GH and IGF-1 through the ghrelin receptor — a different target, a different pathway, and a different risk profile from the androgen-receptor SARMs it’s shelved next to. The “SARM” label is retail shorthand, not pharmacology.
That distinction is practical: it tells you MK-677 won’t suppress testosterone the way a SARM does, but will push blood sugar, fluid, and appetite in ways SARMs don’t. For anyone handling these compounds in research, both classes are unapproved and frequently counterfeited, so third-party purity testing (HPLC and mass spectrometry) is the only reliable way to confirm what’s in a vial. For any decision beyond research, consult a qualified healthcare professional.
This article is for informational and educational purposes only and is not medical advice. MK-677 is not approved for human use.
SARMs as function-promoting therapies — mechanism review (PMC6039107): https://pmc.ncbi.nlm.nih.gov/articles/PMC6039107/
Ghrelin: Structure and Function — GHSR-1a receptor and GH/appetite, Physiological Reviews: https://journals.physiology.org/doi/full/10.1152/physrev.00012.2004
Nass et al. (2008), oral ghrelin mimetic (MK-677) in healthy older adults, Annals of Internal Medicine (PMC2757071): https://pmc.ncbi.nlm.nih.gov/articles/PMC2757071/
Adunsky et al. (2011), MK-0677 hip-fracture trial stopped early for congestive heart failure (PMID 21067829): https://pubmed.ncbi.nlm.nih.gov/21067829/
World Anti-Doping Agency — Prohibited List (growth hormone secretagogues, class S2): https://www.wada-ama.org/en/prohibited-list
MK-677 never touches IGF-1 directly — yet it’s one of the most reliable ways to raise it. The increase is entirely second-hand: MK677 raises growth hormone, and growth hormone tells your liver to make IGF-1. Follow that chain and you understand both why the IGF-1 rise is so consistent and why it carries the caveats …
Meet MK-677, also known as Ibutamoren. It’s not a SARM. Let’s get that out of the way early. It merely loiters in the same online forums, gets mistaken for one due to guilt by association, and is occasionally found wearing a hoodie that says “anabolic.” But scientifically? It’s a growth hormone secretagogue. A fancy term …
You’ve likely heard conflicting opinions: some say SARMs are “side-effect free,” while others claim they got puffy nipples after just a few weeks. Let’s break down the actual science of how SARMs may (or may not) cause gyno, what’s driving the risk, and how researchers manage it in controlled settings. Key Takeaways First, What Is …
Let’s be honest: The SARMs market is flooded with bold claims, sketchy suppliers, and zero accountability. So how do you cut through the noise and find a brand you can actually trust? Here’s a proven step-by-step approach: 1. Start With UK-Based Companies If you’re in the UK, go local.Why? Faster shipping, no customs headaches, and …
Hurry while stocks last! Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for
Join the WaitlistWe will inform you when the product is back in stock. Enter your email address below.
Is MK-677 a SARM? What It Actually Is — and Why the Label Is Wrong
MK-677 sits on every “SARMs” shelf, gets stacked into SARM cycles, and shows up in SARM reviews — so it’s reasonable to assume it’s one. It isn’t. MK-677 is a growth hormone secretagogue, a completely different class of compound that works through a different receptor and produces a different set of effects.
The mix-up is understandable, but it matters: the two classes diverge on mechanism, side effects, hormone suppression, and how you’d even think about using them in research. Below, we explain what a SARM actually is, what MK-677 actually is, why they keep getting lumped together, and the differences that the “SARM” label hides.
Key Takeaways
The short answer: is MK-677 a SARM?
No. A SARM is a selective androgen receptor modulator — the name literally describes its mechanism: it modulates the androgen receptor, the same receptor testosterone uses. MK-677 doesn’t touch the androgen receptor. It works on an entirely separate system that controls growth hormone.
So while MK-677 is sold alongside SARMs and used for overlapping goals (muscle, recovery), calling it a SARM is a category error — like calling a diesel engine “a type of electric motor” because both move a car.
What is a SARM?
SARMs (selective androgen receptor modulators) are nonsteroidal compounds designed to stimulate the androgen receptor in muscle and bone — delivering the muscle-building effects of anabolic steroids while aiming for weaker effects in other tissues like the prostate (overview of SARMs as function-promoting therapies).
Examples you’ll recognize:
The defining feature: they all work by binding the androgen receptor. That single mechanism is what makes something a SARM.
Further reading : What are SARMs?
What is MK-677?
MK-677 — also called ibutamoren or MK-0677 (PubChem CID 178024) — is an oral growth hormone secretagogue. It mimics ghrelin, the body’s “hunger hormone,” binding the growth hormone secretagogue receptor (GHSR-1a) to make your pituitary release more of your own growth hormone (GH). That, in turn, raises insulin-like growth factor 1 (IGF-1).
In the largest human study — a two-year trial in healthy older adults — MK-677 raised GH and IGF-1 to young-adult levels and increased fat-free mass. Note what that mechanism is about: growth hormone, not androgens.
Further reading : What is MK677?
The core difference: two different receptors
This is the whole answer in one line: SARMs and MK-677 act on different receptors, so they’re different drug classes.
Same shelf, same goals — but mechanistically they have almost nothing in common.
Side effects: MK-677 vs SARMs
Because they act on different receptors, the two classes carry different side-effect profiles — which is the most practical reason the distinction matters. Expecting “SARM side effects” from MK-677 (or vice versa) will point you at the wrong risks. Here’s the split, with deeper guides for each.
MK-677 side effects
MK-677’s risks follow from raising growth hormone and IGF-1, not from androgens. The main ones documented in trials:
For the full breakdown — mechanisms, evidence quality, and how trials managed them — see our dedicated guide: What are the side effects of MK-677?
SARM side effects
SARM risks follow from acting on the androgen receptor — a profile MK-677 doesn’t share:
For the detail on each SARM and how their risks differ, see our guide: SARMs side effects
Why MK-677 gets mislabeled as a SARM
If they’re so different, why the constant confusion? A few reasons:
Does the distinction actually matter?
Yes — and not as pedantry. The label changes what you’d expect:
Getting the class right is how you anticipate the right risks.
What MK-677 and SARMs do share
To be fair, the grouping isn’t random. They genuinely overlap on the things a buyer notices:
These shared regulatory traits — not shared pharmacology — are what put them on the same shelf.
Frequently asked questions
Is MK-677 a SARM or a steroid?
Neither. It’s a growth hormone secretagogue (a ghrelin-receptor agonist). It doesn’t act on the androgen receptor like a SARM, and it isn’t an anabolic steroid.
Does MK-677 suppress testosterone like SARMs do?
No. SARMs suppress natural testosterone because they act on the androgen receptor. MK-677 works on the growth hormone pathway and doesn’t directly suppress testosterone.
Why is MK-677 sold with SARMs then?
Marketing and use-case, not pharmacology. Vendors group non-steroidal performance compounds together, and MK-677 is often stacked with SARMs — so it inherits the label.
Is MK-677 safer than a SARM because it’s not one?
Not necessarily — just different. It avoids androgenic suppression but carries its own risks: blood-sugar disruption, water retention, and a cardiovascular signal in trials.
Where can I buy MK677?
You can buy MK677 here, or alternatively buy sarms here
The bottom line
MK-677 is not a SARM. It’s a growth hormone secretagogue that raises your own GH and IGF-1 through the ghrelin receptor — a different target, a different pathway, and a different risk profile from the androgen-receptor SARMs it’s shelved next to. The “SARM” label is retail shorthand, not pharmacology.
That distinction is practical: it tells you MK-677 won’t suppress testosterone the way a SARM does, but will push blood sugar, fluid, and appetite in ways SARMs don’t. For anyone handling these compounds in research, both classes are unapproved and frequently counterfeited, so third-party purity testing (HPLC and mass spectrometry) is the only reliable way to confirm what’s in a vial. For any decision beyond research, consult a qualified healthcare professional.
This article is for informational and educational purposes only and is not medical advice. MK-677 is not approved for human use.
Sources
Related Posts
How Does MK-677 Increase IGF-1?
MK-677 never touches IGF-1 directly — yet it’s one of the most reliable ways to raise it. The increase is entirely second-hand: MK677 raises growth hormone, and growth hormone tells your liver to make IGF-1. Follow that chain and you understand both why the IGF-1 rise is so consistent and why it carries the caveats …
Your guide to MK-677
Meet MK-677, also known as Ibutamoren. It’s not a SARM. Let’s get that out of the way early. It merely loiters in the same online forums, gets mistaken for one due to guilt by association, and is occasionally found wearing a hoodie that says “anabolic.” But scientifically? It’s a growth hormone secretagogue. A fancy term …
How Do SARMs Cause Gyno? (What Research Actually Says & How to Prevent It
You’ve likely heard conflicting opinions: some say SARMs are “side-effect free,” while others claim they got puffy nipples after just a few weeks. Let’s break down the actual science of how SARMs may (or may not) cause gyno, what’s driving the risk, and how researchers manage it in controlled settings. Key Takeaways First, What Is …
How to find the best company for SARMS in the UK
Let’s be honest: The SARMs market is flooded with bold claims, sketchy suppliers, and zero accountability. So how do you cut through the noise and find a brand you can actually trust? Here’s a proven step-by-step approach: 1. Start With UK-Based Companies If you’re in the UK, go local.Why? Faster shipping, no customs headaches, and …